A new prediction model for distinguishing skin sensitisers based on IL-18 release from reconstructed epidermis: enhancing the assessment of a key event in the skin sensitisation adverse outcome pathway
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.